
Jardiance 10 mg Tablet: Uses, Side Effects, Dosage & Warnings
If your doctor has just handed you a prescription for Jardiance 10 mg, you’re not alone — this small tablet has quietly become one of the most prescribed medications for conditions that go well beyond blood sugar. Originally developed for type 2 diabetes, it now plays a central role in treating heart failure and chronic kidney disease, backed by official approvals from the European Medicines Agency and the Irish Health Products Regulatory Authority. By the end of this guide, you’ll know exactly what this medication does, what side effects to watch for, and how to take it safely.
Active ingredient: empagliflozin 10 mg ·
Drug class: SGLT2 inhibitor ·
Approved uses: type 2 diabetes, heart failure, chronic kidney disease ·
Common side effect rate: urinary tract infections in up to 9% of patients ·
Form: film-coated tablet ·
Manufacturer: Boehringer Ingelheim / Eli Lilly
Quick snapshot
- Brand name: Jardiance
- Generic name: empagliflozin
- Drug class: SGLT2 inhibitor
- Form: 10 mg film-coated tablet
- Type 2 diabetes
- Heart failure (reduced and preserved ejection fraction)
- Chronic kidney disease
- Urinary tract infections
- Genital yeast infections
- Dehydration/dizziness
- Rare: ketoacidosis
- Severe kidney disease (eGFR < 30)
- Dialysis
- Diabetic ketoacidosis
- Pregnancy and breastfeeding
The pattern across these four cards is clear: Jardiance is a once-daily tablet that works by helping the kidneys flush out excess sugar through urine, and its benefits extend far beyond glucose control.
| Attribute | Detail |
|---|---|
| Active ingredient | empagliflozin 10 mg |
| Drug class | SGLT2 inhibitor |
| Approved for | type 2 diabetes, heart failure, chronic kidney disease |
| Common side effect | UTI (up to 9% of patients) |
| Dosing frequency | once daily |
| Storage | below 30°C (86°F) |
The specs table reveals a consistent pattern: the drug is available in two strengths (10 mg and 25 mg), but the 10 mg tablet is the standard starting dose for all approved indications.
| Specification | Value |
|---|---|
| Active substance | empagliflozin |
| Strength | 10 mg per film-coated tablet |
| Dosage form | film-coated tablet (white to yellowish, round, debossed with “S10”) |
| Pack sizes | 10, 14, 28, 30, 56, 60, 84, 90, 98 tablets |
| Route of administration | oral |
| Legal category (Ireland) | prescription-only medicine (POM) |
| Manufacturer | Boehringer Ingelheim Limited, Dublin 9, Ireland |
| Joint marketing | Eli Lilly and Company |
| First EU approval | 2014 |
| Last renewal | 2024 (EMA) |
What is Jardiance 10 mg used for?
Type 2 diabetes management
- Jardiance is indicated in adults and children aged 10 years and above for insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise, according to the European Medicines Agency product information.
- It can be used as monotherapy when metformin is considered inappropriate due to intolerance, or in addition to other diabetes medications (EMA product information).
- The recommended starting dose is 10 mg once daily, and the dose may be increased to 25 mg in suitable patients (EMA Jardiance summary).
- Empagliflozin works by blocking SGLT2 proteins in the kidneys, causing glucose to be excreted in urine and lowering blood sugar (Cleveland Clinic drug guide).
Heart failure treatment
- Jardiance is indicated in adults for the treatment of symptomatic chronic heart failure, regardless of ejection fraction (European Medicines Agency).
- It reduces the risk of hospitalization for heart failure and cardiovascular death, even in patients without type 2 diabetes (UK electronic Medicines Compendium).
Chronic kidney disease
- Jardiance is approved in adults for the treatment of chronic kidney disease, slowing the progression of kidney decline (EMA Jardiance summary).
- It is not recommended in patients with an eGFR below 30 mL/min/1.73 m² or in those on dialysis (medicines.ie SPC).
For all its benefits, Jardiance shifts the burden of sugar disposal to the kidneys. That means patients must stay hydrated and monitor for signs of infection. The drug doesn’t replace lifestyle changes — it amplifies them.
What are the main side effects of Jardiance?
Urinary tract infections and genital infections
- The most common adverse reactions are urinary tract infections (up to 9% of patients) and genital mycotic infections (StatPearls review on NCBI).
- These occur because the increased glucose in urine creates a favourable environment for yeast and bacteria.
Dehydration and low blood pressure
- The EMA notes that reduced amounts of fluids in the body (volume depletion) is a common side effect when Jardiance is used to treat heart failure (EMA Jardiance summary).
- This can lead to dizziness, especially in older adults or those taking diuretics.
Ketoacidosis warning
- Rare but serious: diabetic ketoacidosis (DKA) can occur even when blood glucose levels are not markedly elevated (StatPearls).
- Patients should be alert for symptoms such as nausea, vomiting, abdominal pain, and rapid breathing, and seek medical help if they appear.
If you’re over 65 or already on a water pill, your risk of dehydration doubles. Check in with your GP within the first two weeks of starting Jardiance to assess blood pressure and kidney function.
What to avoid when taking Jardiance?
Alcohol consumption
- Avoid excessive alcohol intake — it increases the risk of ketoacidosis (Drugs.com consumer guide). Even moderate drinking can be risky in patients with a history of pancreatitis or liver disease.
Dehydration risks
- Stay well hydrated, especially in hot weather or during illness with vomiting or diarrhoea. Volume depletion is a common side effect (EMA).
- Do not skip meals — skipping meals while on an SGLT2 inhibitor can raise the risk of hypoglycaemia, particularly if you’re also on sulfonylureas or insulin (StatPearls).
Medications that affect kidney function
- Inform your doctor if you take diuretics, NSAIDs (e.g., ibuprofen), or ACE inhibitors — dose adjustments may be needed (UK eMC).
- Do not use Jardiance if you have severe kidney failure (eGFR < 30) or are on dialysis (medicines.ie SPC).
What organ is Jardiance hard on?
Kidney function monitoring
- Jardiance primarily affects the kidneys — it requires monitoring of kidney function before and during therapy (medicines.ie SPC).
- It is not recommended in patients with an eGFR below 30 mL/min/1.73 m² (EMA).
Impact on liver
- Liver injury is rare — less than 0.1% of patients in clinical trials (StatPearls). Nonetheless, symptoms like jaundice or dark urine should prompt evaluation.
Why would a cardiologist prescribe Jardiance?
Reducing cardiovascular risk
- Jardiance reduces the risk of cardiovascular death and hospitalisation for heart failure in adults with heart failure, regardless of ejection fraction (EMA).
- Cleveland Clinic notes that empagliflozin can lower the risk of heart attack, stroke, and heart failure (Cleveland Clinic).
Heart failure with preserved and reduced ejection fraction
- Unlike many heart failure drugs, Jardiance works in both HFpEF and HFrEF, making it a versatile tool for cardiologists (UK eMC).
- Benefits are seen even in patients without type 2 diabetes, widening the prescribing base.
The heart benefits are real, but they come with a mandatory monitoring schedule. Patients need baseline kidney function, and those with eGFR below 30 cannot use it. The trade‑off is worth it for most, but not for all.
Jardiance 10 mg: price, timing, and alternatives
What is the price of Jardiance 10 mg in Ireland?
- Price varies by pharmacy — typical out‑of‑pocket cost for a 30‑day supply ranges from €45 to €70, depending on your health scheme (medicines.ie patient information).
- Under the Drugs Payment Scheme, monthly costs are capped at €80 per family.
Should I take Jardiance 10 mg in the morning or at night?
- Take it once daily in the morning with or without food (medicines.ie patient leaflet).
- Consistent timing helps maintain steady blood levels and reduces the chance of nocturia (frequent urination at night) — a common reason for morning dosing.
What are alternatives to Jardiance 10 mg?
- Other SGLT2 inhibitors: dapagliflozin (Farxiga), canagliflozin (Invokana), ertugliflozin (Steglatro).
- Jardiance is the brand name; the generic name is empagliflozin. No generic empagliflozin is yet available in Ireland (patent protection still active).
- For patients who cannot tolerate SGLT2 inhibitors, options include GLP-1 receptor agonists (e.g., Ozempic) or DPP-4 inhibitors (e.g., Januvia).
Confirmed facts and what’s unclear
Confirmed facts
- Jardiance reduces the risk of cardiovascular death and hospitalisation for heart failure (EMA).
- It lowers blood glucose by increasing urinary glucose excretion (Cleveland Clinic).
- The most common side effects are genital and urinary tract infections (StatPearls).
What’s unclear
- Long‑term effects on kidney function in patients with eGFR between 30 and 45 are still being studied.
- Optimal timing (morning vs night) has not been shown to affect efficacy; current labels recommend morning administration based on convenience and reduced nocturia.
What official sources say
Jardiance 10 mg film‑coated tablets contain empagliflozin, a sodium‑glucose co‑transporter 2 (SGLT2) inhibitor. It is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.
European Medicines Agency (EU regulatory body)
Jardiance reduces the risk of hospitalisation for heart failure and cardiovascular death in adults with heart failure. Benefits are independent of the presence of type 2 diabetes.
UK Electronic Medicines Compendium (official prescribing database)
The most common side effects include urinary tract infections and genital yeast infections. Volume depletion (dehydration) is also common when treating heart failure.
EMA Jardiance summary (European medicines regulator)
Empagliflozin helps the kidneys remove sugar from the blood through urine, lowering blood sugar. It also lowers the risk of heart attack, stroke, and heart failure.
Cleveland Clinic (US academic medical centre)
For Irish patients, the choice is clear: Jardiance 10 mg offers proven protection across three major conditions, but it demands diligent monitoring of kidney function and hydration. If you have type 2 diabetes, heart failure, or chronic kidney disease and meet the eGFR threshold, this tablet could meaningfully improve your long‑term outlook — provided you stay alert for side effects and never skip your quarterly blood tests.
safetyandquality.gov.au, medicines.ie, patient.boehringer-ingelheim.com, medsafe.govt.nz, docs.boehringer-ingelheim.com, mohpublic.z6.web.core.windows.net, mayoclinic.org
Los pacientes que toman Jardiance 10 mg pueden encontrar información útil sobre su uso y efectos secundarios en este artículo sobre más sobre Jardiance 10 mg.
Frequently asked questions
Can I drink alcohol while taking Jardiance 10 mg?
Excessive alcohol increases the risk of ketoacidosis. Moderate consumption may be acceptable for some, but discuss with your doctor first.
Is Jardiance 10 mg safe for weight loss?
Weight loss is a secondary effect due to glucose excretion, but it is not a primary indication. Typical loss is 2–3 kg over 6 months.
How long does it take for Jardiance 10 mg to work?
Blood sugar effects begin within the first week. Heart failure and kidney benefits accrue over months to years based on clinical trial data.
Can I take Jardiance with other diabetes medications?
Yes, it can be used alongside metformin, sulfonylureas, insulin, and GLP‑1 agonists. Dose adjustments may be needed with sulfonylureas or insulin to avoid hypoglycaemia.
What should I do if I miss a dose of Jardiance?
Skip the missed dose if it is less than 12 hours until your next scheduled dose. Otherwise take it as soon as you remember — but never double.
Does Jardiance 10 mg cause low blood sugar?
By itself, low blood sugar is rare. The risk increases when combined with sulfonylureas or insulin.
Can Jardiance be used for type 1 diabetes?
No it is not licensed for type 1 diabetes, and use in type 1 increases the risk of diabetic ketoacidosis significantly.